 | • レポートコード：MRC23Q36334 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、62ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のRho関連プロテインキナーゼ2市場について調査・分析し、世界のRho関連プロテインキナーゼ2市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（AN-3485、KL-01045、AT-13148、TRX-101、その他）、用途別セグメント分析（緑内障、線維症、脊髄、免疫療法、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Aerie Pharmaceuticals、DWTIなどが含まれています。世界のRho関連プロテインキナーゼ2市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、Rho関連プロテインキナーゼ2市場規模を推定する際に考慮しました。本レポートは、Rho関連プロテインキナーゼ2の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、Rho関連プロテインキナーゼ2に関するビジネス上の意思決定に役立てることを目的としています。 ・Rho関連プロテインキナーゼ2市場の概要 - Rho関連プロテインキナーゼ2のタイプ別セグメント - 世界のRho関連プロテインキナーゼ2市場規模：タイプ別分析（AN-3485、KL-01045、AT-13148、TRX-101、その他） - Rho関連プロテインキナーゼ2の用途別セグメント - 世界のRho関連プロテインキナーゼ2市場規模：用途別分析（緑内障、線維症、脊髄、免疫療法、その他） - 世界のRho関連プロテインキナーゼ2市場規模予測（2018年-2029年） ・Rho関連プロテインキナーゼ2市場の成長トレンド - Rho関連プロテインキナーゼ2の地域別市場規模（2018年-2029年） - Rho関連プロテインキナーゼ2市場ダイナミクス - Rho関連プロテインキナーゼ2の業界動向 - Rho関連プロテインキナーゼ2市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：AN-3485、KL-01045、AT-13148、TRX-101、その他 - 世界のRho関連プロテインキナーゼ2のタイプ別市場規模（2018年-2023年） - 世界のRho関連プロテインキナーゼ2のタイプ別市場規模（2024年-2029年） ・用途別セグメント：緑内障、線維症、脊髄、免疫療法、その他 - 世界のRho関連プロテインキナーゼ2の用途別市場規模（2018年-2023年） - 世界のRho関連プロテインキナーゼ2の用途別市場規模（2024年-2029年） ・Rho関連プロテインキナーゼ2の地域別市場規模 - 北米のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - アメリカのRho関連プロテインキナーゼ2市場規模（2018年-2029年） - ヨーロッパのRho関連プロテインキナーゼ2市場規模（2018年-2029年） - アジア太平洋のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - 中国のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - 日本のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - 韓国のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - インドのRho関連プロテインキナーゼ2市場規模（2018年-2029年） - オーストラリアのRho関連プロテインキナーゼ2市場規模（2018年-2029年） - 中南米のRho関連プロテインキナーゼ2市場規模（2018年-2029年） - 中東・アフリカのRho関連プロテインキナーゼ2市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Aerie Pharmaceuticals、DWTI ・アナリストの観点/結論 ・調査方法とデータソース |
Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.
Highlights
The global Rho Associated Protein Kinase 2 market was valued at US$ 272.2 million in 2022 and is anticipated to reach US$ 817 million by 2029, witnessing a CAGR of 20.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share more than 50%, It was followed by Asia-Pacific with 35%. Aerie Pharmaceuticals and DWTI are 2 players of Rho Associated Protein Kinase 2, and Aerie Pharmaceuticals hold about 60% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rho Associated Protein Kinase 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rho Associated Protein Kinase 2.
The Rho Associated Protein Kinase 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rho Associated Protein Kinase 2 market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rho Associated Protein Kinase 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Aerie Pharmaceuticals
DWTI
Segment by Type
AN-3485
KL-01045
AT-13148
TRX-101
Others
Segment by Application
Glaucoma
Fibrosis
Spinal Cord
Immune Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rho Associated Protein Kinase 2 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rho Associated Protein Kinase 2 Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 AN-3485
1.2.3 KL-01045
1.2.4 AT-13148
1.2.5 TRX-101
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rho Associated Protein Kinase 2 Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Glaucoma
1.3.3 Fibrosis
1.3.4 Spinal Cord
1.3.5 Immune Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rho Associated Protein Kinase 2 Market Perspective (2018-2029)
2.2 Rho Associated Protein Kinase 2 Growth Trends by Region
2.2.1 Global Rho Associated Protein Kinase 2 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rho Associated Protein Kinase 2 Historic Market Size by Region (2018-2023)
2.2.3 Rho Associated Protein Kinase 2 Forecasted Market Size by Region (2024-2029)
2.3 Rho Associated Protein Kinase 2 Market Dynamics
2.3.1 Rho Associated Protein Kinase 2 Industry Trends
2.3.2 Rho Associated Protein Kinase 2 Market Drivers
2.3.3 Rho Associated Protein Kinase 2 Market Challenges
2.3.4 Rho Associated Protein Kinase 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rho Associated Protein Kinase 2 Players by Revenue
3.1.1 Global Top Rho Associated Protein Kinase 2 Players by Revenue (2018-2023)
3.1.2 Global Rho Associated Protein Kinase 2 Revenue Market Share by Players (2018-2023)
3.2 Global Rho Associated Protein Kinase 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rho Associated Protein Kinase 2 Revenue
3.4 Global Rho Associated Protein Kinase 2 Market Concentration Ratio
3.4.1 Global Rho Associated Protein Kinase 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rho Associated Protein Kinase 2 Revenue in 2022
3.5 Rho Associated Protein Kinase 2 Key Players Head office and Area Served
3.6 Key Players Rho Associated Protein Kinase 2 Product Solution and Service
3.7 Date of Enter into Rho Associated Protein Kinase 2 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rho Associated Protein Kinase 2 Breakdown Data by Type
4.1 Global Rho Associated Protein Kinase 2 Historic Market Size by Type (2018-2023)
4.2 Global Rho Associated Protein Kinase 2 Forecasted Market Size by Type (2024-2029)
5 Rho Associated Protein Kinase 2 Breakdown Data by Application
5.1 Global Rho Associated Protein Kinase 2 Historic Market Size by Application (2018-2023)
5.2 Global Rho Associated Protein Kinase 2 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rho Associated Protein Kinase 2 Market Size (2018-2029)
6.2 North America Rho Associated Protein Kinase 2 Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rho Associated Protein Kinase 2 Market Size by Country (2018-2023)
6.4 North America Rho Associated Protein Kinase 2 Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rho Associated Protein Kinase 2 Market Size (2018-2029)
7.2 Europe Rho Associated Protein Kinase 2 Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rho Associated Protein Kinase 2 Market Size by Country (2018-2023)
7.4 Europe Rho Associated Protein Kinase 2 Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rho Associated Protein Kinase 2 Market Size (2018-2029)
8.2 Asia-Pacific Rho Associated Protein Kinase 2 Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rho Associated Protein Kinase 2 Market Size by Region (2018-2023)
8.4 Asia-Pacific Rho Associated Protein Kinase 2 Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rho Associated Protein Kinase 2 Market Size (2018-2029)
9.2 Latin America Rho Associated Protein Kinase 2 Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rho Associated Protein Kinase 2 Market Size by Country (2018-2023)
9.4 Latin America Rho Associated Protein Kinase 2 Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rho Associated Protein Kinase 2 Market Size (2018-2029)
10.2 Middle East & Africa Rho Associated Protein Kinase 2 Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rho Associated Protein Kinase 2 Market Size by Country (2018-2023)
10.4 Middle East & Africa Rho Associated Protein Kinase 2 Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aerie Pharmaceuticals
11.1.1 Aerie Pharmaceuticals Company Detail
11.1.2 Aerie Pharmaceuticals Business Overview
11.1.3 Aerie Pharmaceuticals Rho Associated Protein Kinase 2 Introduction
11.1.4 Aerie Pharmaceuticals Revenue in Rho Associated Protein Kinase 2 Business (2018-2023)
11.1.5 Aerie Pharmaceuticals Recent Development
11.2 DWTI
11.2.1 DWTI Company Detail
11.2.2 DWTI Business Overview
11.2.3 DWTI Rho Associated Protein Kinase 2 Introduction
11.2.4 DWTI Revenue in Rho Associated Protein Kinase 2 Business (2018-2023)
11.2.5 DWTI Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details